Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pergolide helps manage equine PPID, study finds
The pergolide treatment did not have any effect on horses which were diagnosed with ID only.
The drug reduced blood insulin levels in horses with both PPID and ID.

A new study has highlighted the benefits of using pergolide mesylate to treat horses diagnosed with pituitary pars intermedia dysfunction (PPID).

The drug, which is already commonly used for treating the condition, proved to be effective in reducing the amount of insulin produced by horses when eating.

PPID, also known as Cushing's syndrome, affects the pituitary gland at the base of a horse's brain which produces hormones in response to brain signals. When damaged due to PPID, there can be excessive production of normal hormones, leading to issues such as laminitis and weight loss.

The risk of developing laminitis is higher in horses also diagnosed with insulin dysregulation (ID). A high concentration of insulin is now recognised as the leading cause of laminitis in the UK.

A research project, published by the University of Melbourne, sought to investigate how effective pergolide was at managing the clinical signs of PPID.

The study saw 16 senior horses (eight with PPID and ID, eight with ID only) take part in a standard meal test. Researchers measured the horses' insulin concentration before and after they had eaten a high starch meal.

All of the horses did the standard meal test twice, once after four weeks of pergolide treatment and once without pergolide treatment.

The results revealed that pergolide was an effective treatment for horses with both PPID and ID. Horses treated with pergolide recorded blood insulin levels at the same level as horses that only had ID.

However, the pergolide treatment did not have any effect on horses which were diagnosed with ID only. Researchers say that this highlights the importance of testing for PPID and ID separately, as treating one may not manage the other.

The study also found that, even when treated with pergolide, the horses diagnosed with PPID or ID still produced more insulin from starchy, sugary meals than healthy horses. Researchers say that a low sugar and starch diet remains vital for managing horses with PPID and ID.

The full study has been published in the Equine Veterinary Journal.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.